CHICAGO EQUITY PARTNERS LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$1,509,000
-31.3%
15,145
-20.8%
0.15%
+20.6%
Q4 2019$2,196,000
-28.1%
19,115
-21.0%
0.13%
-13.1%
Q3 2019$3,053,000
+49.6%
24,205
+42.7%
0.14%
+59.3%
Q2 2019$2,041,000
+36.5%
16,960
-0.7%
0.09%
+56.9%
Q1 2019$1,495,000
-57.6%
17,085
-51.6%
0.06%
-59.2%
Q4 2018$3,530,000
-34.5%
35,285
-24.9%
0.14%
-10.1%
Q3 2018$5,386,000
-30.7%
47,005
-45.8%
0.16%
-33.6%
Q2 2018$7,772,000
+64.3%
86,665
+34.0%
0.24%
+57.6%
Q1 2018$4,731,000
+297.2%
64,665
+215.3%
0.15%
+319.4%
Q4 2017$1,191,00020,5100.04%
Other shareholders
HAEMONETICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders